Research ExplorerPublicationsEvolving Role of Catheter Ablation for Atrial Fibrillation: ...

Evolving Role of Catheter Ablation for Atrial Fibrillation: Early and Effective Rhythm Control

Standard

Evolving Role of Catheter Ablation for Atrial Fibrillation: Early and Effective Rhythm Control. / Chen, Shaojie; Yin, Yuehui; Ling, Zhiyu; Meyer, Christian; Pürerfellner, Helmut; Martinek, Martin; Kiuchi, Márcio Galindo; Futyma, Piotr; Zhu, Lin; Schratter, Alexandra; Wang, Jiazhi; Acou, Willem-Jan; Sommer, Philipp; Ouyang, Feifan; Liu, Shaowen; Chun, Julian K R; Schmidt, Boris.

In: J CLIN MED, Vol. 11, No. 22, 6871, 21.11.2022.

Research output: SCORING: Contribution to journal › SCORING: Review article › Research

Harvard

Chen, S, Yin, Y, Ling, Z, Meyer, C, Pürerfellner, H, Martinek, M, Kiuchi, MG, Futyma, P, Zhu, L, Schratter, A, Wang, J, Acou, W-J, Sommer, P, Ouyang, F, Liu, S, Chun, JKR & Schmidt, B 2022, 'Evolving Role of Catheter Ablation for Atrial Fibrillation: Early and Effective Rhythm Control', J CLIN MED, vol. 11, no. 22, 6871. https://doi.org/10.3390/jcm11226871

APA

Chen, S., Yin, Y., Ling, Z., Meyer, C., Pürerfellner, H., Martinek, M., Kiuchi, M. G., Futyma, P., Zhu, L., Schratter, A., Wang, J., Acou, W-J., Sommer, P., Ouyang, F., Liu, S., Chun, J. K. R., & Schmidt, B. (2022). Evolving Role of Catheter Ablation for Atrial Fibrillation: Early and Effective Rhythm Control. J CLIN MED, 11(22), [6871]. https://doi.org/10.3390/jcm11226871

Vancouver

Chen S, Yin Y, Ling Z, Meyer C, Pürerfellner H, Martinek M et al. Evolving Role of Catheter Ablation for Atrial Fibrillation: Early and Effective Rhythm Control. J CLIN MED. 2022 Nov 21;11(22). 6871. https://doi.org/10.3390/jcm11226871

Bibtex

@article{874732cb40cc425a84be3228a1f498dc,
title = "Evolving Role of Catheter Ablation for Atrial Fibrillation: Early and Effective Rhythm Control",
abstract = "Catheter Ablation (CA) is an effective therapeutic option in treating atrial fibrillation (AF). Importantly, recent data show that CA as a rhythm control strategy not only significantly reduces AF burden, but also substantially improves clinical hard endpoints. Since AF is a progressive disease, the time of Diagnosis-to-Intervention appears crucial. Recent evidence shows that earlier rhythm control is associated with a lower risk of adverse cardiovascular outcomes in patients with early AF. Particularly, CA as an initial first line rhythm control strategy is associated with significant reduction of arrhythmia recurrence and rehospitalization in patients with paroxysmal AF. CA is shown to significantly lower the risk of progression from paroxysmal AF to persistent AF. When treating persistent AF, the overall clinical success after ablation remains unsatisfactory, however the ablation outcome in patients with {"}early{"} persistent AF appears better than those with {"}late{"} persistent AF. {"}Adjunctive{"} ablation on top of pulmonary vein isolation (PVI), e.g., ablation of atrial low voltage area, left atrial posterior wall, vein of Marshall, left atrial appendage, etc., may further reduce arrhythmia recurrence in selected patient group. New ablation concepts or new ablation technologies have been developing to optimize therapeutic effects or safety profile and may ultimately improve the clinical outcome.",
author = "Shaojie Chen and Yuehui Yin and Zhiyu Ling and Christian Meyer and Helmut P{\"u}rerfellner and Martin Martinek and Kiuchi, {M{\'a}rcio Galindo} and Piotr Futyma and Lin Zhu and Alexandra Schratter and Jiazhi Wang and Willem-Jan Acou and Philipp Sommer and Feifan Ouyang and Shaowen Liu and Chun, {Julian K R} and Boris Schmidt",
year = "2022",
month = nov,
day = "21",
doi = "10.3390/jcm11226871",
language = "English",
volume = "11",
journal = "J CLIN MED",
issn = "2077-0383",
publisher = "MDPI AG",
number = "22",

}

RIS

TY - JOUR

T1 - Evolving Role of Catheter Ablation for Atrial Fibrillation: Early and Effective Rhythm Control

AU - Chen, Shaojie

AU - Yin, Yuehui

AU - Ling, Zhiyu

AU - Meyer, Christian

AU - Pürerfellner, Helmut

AU - Martinek, Martin

AU - Kiuchi, Márcio Galindo

AU - Futyma, Piotr

AU - Zhu, Lin

AU - Schratter, Alexandra

AU - Wang, Jiazhi

AU - Acou, Willem-Jan

AU - Sommer, Philipp

AU - Ouyang, Feifan

AU - Liu, Shaowen

AU - Chun, Julian K R

AU - Schmidt, Boris

PY - 2022/11/21

Y1 - 2022/11/21

N2 - Catheter Ablation (CA) is an effective therapeutic option in treating atrial fibrillation (AF). Importantly, recent data show that CA as a rhythm control strategy not only significantly reduces AF burden, but also substantially improves clinical hard endpoints. Since AF is a progressive disease, the time of Diagnosis-to-Intervention appears crucial. Recent evidence shows that earlier rhythm control is associated with a lower risk of adverse cardiovascular outcomes in patients with early AF. Particularly, CA as an initial first line rhythm control strategy is associated with significant reduction of arrhythmia recurrence and rehospitalization in patients with paroxysmal AF. CA is shown to significantly lower the risk of progression from paroxysmal AF to persistent AF. When treating persistent AF, the overall clinical success after ablation remains unsatisfactory, however the ablation outcome in patients with "early" persistent AF appears better than those with "late" persistent AF. "Adjunctive" ablation on top of pulmonary vein isolation (PVI), e.g., ablation of atrial low voltage area, left atrial posterior wall, vein of Marshall, left atrial appendage, etc., may further reduce arrhythmia recurrence in selected patient group. New ablation concepts or new ablation technologies have been developing to optimize therapeutic effects or safety profile and may ultimately improve the clinical outcome.

AB - Catheter Ablation (CA) is an effective therapeutic option in treating atrial fibrillation (AF). Importantly, recent data show that CA as a rhythm control strategy not only significantly reduces AF burden, but also substantially improves clinical hard endpoints. Since AF is a progressive disease, the time of Diagnosis-to-Intervention appears crucial. Recent evidence shows that earlier rhythm control is associated with a lower risk of adverse cardiovascular outcomes in patients with early AF. Particularly, CA as an initial first line rhythm control strategy is associated with significant reduction of arrhythmia recurrence and rehospitalization in patients with paroxysmal AF. CA is shown to significantly lower the risk of progression from paroxysmal AF to persistent AF. When treating persistent AF, the overall clinical success after ablation remains unsatisfactory, however the ablation outcome in patients with "early" persistent AF appears better than those with "late" persistent AF. "Adjunctive" ablation on top of pulmonary vein isolation (PVI), e.g., ablation of atrial low voltage area, left atrial posterior wall, vein of Marshall, left atrial appendage, etc., may further reduce arrhythmia recurrence in selected patient group. New ablation concepts or new ablation technologies have been developing to optimize therapeutic effects or safety profile and may ultimately improve the clinical outcome.

U2 - 10.3390/jcm11226871

DO - 10.3390/jcm11226871

M3 - SCORING: Review article

C2 - 36431348

VL - 11

JO - J CLIN MED

JF - J CLIN MED

SN - 2077-0383

IS - 22

M1 - 6871

ER -